Karyn Aalami Goodman, MD, MS

Director Clinical Research, Tisch Cancer Institute, Mount Sinai

Karyn Aalami Goodman, MD, MS is a Professor and Vice Chair for Research and Quality in the Department of Radiation Oncology at the Icahn School of Medicine at Mount Sinai. She is also Associate Director for Clinical Research at The Tisch Cancer Institute and oversees the oncology clinical research program at Mount Sinai.

Dr. Goodman is an internationally recognized expert in gastrointestinal (GI) cancers. She is the national Radiation Oncology principal investigator of the RTOG/NRG 0848 study, a phase III trial evaluating the use of post-operative radiotherapy for pancreatic cancer and the national Study Chair for the recently completed CALGB/Alliance Cooperative Group phase II trial (CALGB 80803) investigating PET scan-directed therapy for esophageal cancer.

She currently serves as the Co-Chair of the National Cancer Institute (NCI) Gastrointestinal Steering Committee where she helps to set the strategic priorities for the development of Phase II and III clinical trials in GI cancers conducted through the National Clinical Trials Network (NCTN).